Loading...
Docoh

Orphazyme A/S (ORPHY)

ORPHY stock data

Calendar

2 Mar 21
26 Jun 22
31 Dec 22
Quarter (USD) Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
21.2% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 26 26
Opened positions 4 8 -50.0%
Closed positions 4 7 -42.9%
Increased positions 7 6 +16.7%
Reduced positions 9 4 +125.0%
13F shares Current Prev Q Change
Total value 47.64M 71.57M -33.4%
Total shares 7.47M 7.27M +2.7%
Total puts 144.4K 228.1K -36.7%
Total calls 325.2K 159.2K +104.3%
Total put/call ratio 0.4 1.4 -69.0%
Largest owners Shares Value Change
LSP V Cooperatieve U.A. 2.6M $6.26M -4.2%
Sunstone Life Science Ventures Fund Ii K/S 1.79M $19.21M 0.0%
Cooperatieve AESCAP Venture I U.A. 1.76M $18.86M 0.0%
Renaissance Technologies 271.99K $656K +150.0%
Geode Capital Management 177.07K $426K +590.6%
Two Sigma Investments 141.12K $340K -41.2%
Profund Advisors 127.52K $307K NEW
Susquehanna International 114.37K $276K -26.5%
Optiver Holding B.V. 106.84K $358K +81.8%
Citadel Advisors 95.01K $229K NEW
Largest transactions Shares Bought/sold Change
Renaissance Technologies 271.99K +163.19K +150.0%
Geode Capital Management 177.07K +151.43K +590.6%
Profund Advisors 127.52K +127.52K NEW
LSP V Cooperatieve U.A. 2.6M -114.67K -4.2%
Two Sigma Investments 141.12K -98.82K -41.2%
Citadel Advisors 95.01K +95.01K NEW
Blueshift Asset Management 0 -82.34K EXIT
UBS UBS Group AG - Registered Shares 70K +67.24K +2431.6%
Simplex Trading 4.62K -64.16K -93.3%
Optiver Holding B.V. 106.84K +48.08K +81.8%

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
Proxies
No filings